US-Based Mayo Clinic Partners Silicon Valley Startup to Develop AI Models for Medical Applications January 10, 2024
Cipla Partners Kemwell & Manipal for Global Cell Therapy Advancements January 9, 2024 Global pharmaceutical company Cipla has joined hands with Kemwell Biopharma and Manipal Education & Medical Group in the US. The joint venture seeks to expedite the development, manufacturing, and distribution of cell therapies.
Merck Bolsters Oncology Portfolio with $680 Mn Acquisition of Harpoon Therapeutics January 9, 2024 The move is pivotal for Merck as it seeks alternative revenue streams, considering potential pricing pressure on its top-selling medicine, the cancer immunotherapy Keytruda.
Amazon Health Launches ‘Health Condition Programs’ to Address Chronic Conditions in the US January 9, 2024 This initiative is part of Amazon Health’s efforts to provide comprehensive, digitally-enabled healthcare services. It is designed to help individuals better manage their health conditions and overall well-being.
Cigna in Exclusive Talks to Sell Medicare Advantage Biz to HCSC for Close to $4 Bn January 8, 2024 Cigna had been actively seeking a buyer since November, with the motivation behind the move revealed during its third-quarter earnings call.
Chicago-Based WellBe Senior Medical Secures Investment from CVS Health Ventures January 8, 2024 Chicago-based WellBe Senior Medical has secured investment from CVS Health Ventures, the corporate venture capital arm of CVS Health. However, the investment amount has not been disclosed yet. This partnership focuses on reducing costs and improving outcomes for clinically complex patients. The investment funds will be utilised to enhance these services and expand their reach across the nation.
Baracoda Unveils World's First Smart Mirror ‘BMind’ for Mental Wellness January 8, 2024 Additionally, BMind gathers information without any invasive technology and helps users incorporate mindfulness practices into their daily routines or even curb feelings of loneliness through an immersive experience using light, sound, and visuals.
Accord BioPharma's DMB-3115 Secures USFDA Approval January 5, 2024 The biosimilar DMB-3115 stands as a potential substitute for STELARA®, a widely-used drug for treating plaque psoriasis, psoriatic arthritis, Crohn's disease, and ulcerative colitis. STELARA® is one of the leading biologics with market sales up to $13.9 billion in 2022.
Eli Lilly Launches Digital Healthcare Platform ‘LillyDirect’ to Help Patients with Chronic Illness January 5, 2024 LillyDirect offers access to independent healthcare providers, direct home delivery of specified Lilly medicines through third-party pharmacy dispensing services. It also provides access to LillyDirect Pharmacy Solutions—a digital pharmacy for consistent access to prescribed medications delivered directly to patients at their homes.
Devoted Health Secures $175 Mn in Series E Funding to Propel Medicare Advantage Services January 5, 2024 This funding is led by a consortium including The Space Between, Highbury Holdings, GIC, Stardust Equity, Maverick Ventures, and Fearless Ventures.
MIT Researchers Discover a New Tool ‘Focused Ultrasound’ to Treat Alzheimer’s Faster January 5, 2024 MIT researchers conducted a pioneering experimental study with the Focused Ultrasound tool on three patients. In early clinical trials, results showed that the brain areas targeted by the tool enhanced the removal of Alzheimer’s trademark brain-clogging plaque.
BJC HealthCare & Saint Luke's Health System Complete $10 Bn Merger January 4, 2024 The merger, effective January 1, brings together two Missouri-based organisations under the umbrella of BJC Health System, boasting 24 hospitals and a workforce of 44,000 employees.